- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
U.S. venture funding of therapeutic companies by disease type 2017
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
U.S. venture funding of therapeutic companies by disease type 2017
Venture funding of U.S. therapeutic companies in 2017, by disease type (in million U.S. dollars)
by Matej Mikulic,
last edited
Jun 5, 2018
This graph shows venture funding of U.S. therapeutic companies for the year 2017, sorted by disease type, in million U.S. dollars. In that year, venture funding for oncology totaled over 2.9 billion U.S. dollars.
Venture funding of U.S. therapeutic companies in 2017, by disease type (in million U.S. dollars)
| Total venture funding raised in million U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Total venture funding raised in million U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Jun 5, 2018
This graph shows venture funding of U.S. therapeutic companies for the year 2017, sorted by disease type, in million U.S. dollars. In that year, venture funding for oncology totaled over 2.9 billion U.S. dollars.
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- June 2018
- Region
- United States
- Survey time period
- 2017
Source
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- June 2018
More information
- Region
- United States
- Survey time period
- 2017
Other statistics on the topic
+Pharmaceutical Products & Market
Leading pharmaceutical companies in Norway 2017, by turnover
+Pharmaceutical Products & Market
Value of pharmaceutical sales in Norway 2000-2017
+Pharmaceutical Products & Market
Leading pharmaceutical companies in Norway 2017, by market share
+Pharmaceutical Products & Market
Pharmaceutical preparations: manufacturing turnover in Norway 2007-2015
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Pharmaceutical industry in Norway "
- Overview
The most important statistics
- Value of pharmaceutical sales in Norway from 2000 to 2017 (in milllion NOK) Value of pharmaceutical sales in Norway 2000-2017
- Leading pharmaceutical companies in Norway in 2017, by turnover (in million NOK) Leading pharmaceutical companies in Norway 2017, by turnover
- Leading pharmaceutical companies in Norway in 2017, by market share Leading pharmaceutical companies in Norway 2017, by market share
- Producer price index (PPI) of chemical and pharmaceutical products in Norway from 2008 to 2018producer price index of chemical and pharmaceutical products in Norway 2008-2018
- Public expenditure on blue prescriptions in Norway from 2013 to 2017 (in billion NOK) Public expenditure on blue prescriptions in Norway 2013-2017
- Number of pharmaceuticals available in Norway from 2013 to 2017 Number of pharmaceuticals available in Norway 2013-2017
- Leading nonprescription pharmaceutical companies in Norway in 2017, by market share Leading nonprescription pharmaceutical companies in Norway 2017, by market share
- Production and trade
The most important statistics
- Turnover of pharmaceutical preparation manufacturers in Norway from 2007 to 2015 (in million NOK)Pharmaceutical preparations: manufacturing turnover in Norway 2007-2015
- Number of establishments in the manufacture of pharmaceutical preparations industry in Norway from 2007 to 2017Number of pharmaceutical preparation establishments in Norway 2007-2017
- Number of employees in the manufacture of pharmaceutical preparations industry in Norway from 2007 to 2017Number of employees in pharmaceutical industry in Norway 2007-2017
- Import and export value of basic pharmaceutical products and pharmaceutical preparations in Norway in 2018 (in million NOK)Import and export value of basic pharmaceuticals in Norway 2018
- Import value of basic pharmaceutical products and pharmaceutical preparations into Norway from 2008 to 2018 (in million NOK)Import value of basic pharmaceuticals and preparations into Norway 2008-2018
- Export value of basic pharmaceutical products and pharmaceutical preparations from Norway from 2008 to 2018 (in million NOK)Export value of basic pharmaceuticals and preparations from Norway 2008-2018
- Pharmaceutical turnover
The most important statistics
- Turnover share of prescription pharmaceuticals in Norway in 2017, by prescription type (in million NOK) Turnover share of prescription drugs in Norway 2017, by prescription type
- Turnover of pharmaceuticals in Norway in 2017, by prescription type (in million NOK) Turnover of pharmaceuticals in Norway 2017, by prescription type
- Turnover share of generic pharmaceuticals in Norway from 2013 to 2017 Turnover share of generic pharmaceuticals in Norway 2013-2017
- Turnover of pharmaceuticals in Norway in 2017, by type of drug (in million NOK)Turnover of pharmaceuticals in Norway 2017, by type of drug
- Turnover of pharmaceuticals in Norway in 2017, by ATC main groups (in million NOK) Turnover of pharmaceuticals in Norway 2017, by ATC main groups
- Turnover of nonprescription drugs in Norway from 2013 to 2017 (in million NOK) Turnover of nonprescription drugs in Norway 2013-2017
- R&D, patents and new products
The most important statistics
- Number of patents in the biotechnology sector in Norway from 2011 to 2016Number of biotechnology patents in Norway 2011-2016
- Number of applications for clinical trials in Norway from 2013 to 2017 Number of applications for clinical trials in Norway 2013-2017
- Number of applications for clinical trials in Norway from 2013 to 2017, by type of actor Number of applications for clinical trials in Norway 2013-2017, by type of actor
- Volume share of pharmaceutical sales Norway in 2016, by introduction date Volume share of pharmaceutical sales in Norway 2016, by introduction date
- Number of new cancer pharmaceuticals approved by the European Medicines Agency (EMA) in Norway from 2014 to 2017 Number of new cancer pharmaceuticals approved by EMA in Norway 2014-2017
- Number of new and expired active substances in Norway from 2013 to 2017 Number of new and expired active substances in Norway 2013-2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Total U.S. disease investment 2008-2017 by disease
- Worldwide therapeutic licensing and acquisition deals 2008-2017 by disease type
- U.S. disease investment by share of disease and investment type 2008-2017
- U.S. number of venture capital deals for neurology companies 2006-2017
- U.S. venture investments in infectious disease companies from 2006 to 2017
- U.S. number of venture capital deals for infectious disease companies 2006-2017
- U.S. number of venture capital deals for oncology companies 2006-2017
- U.S. number of IPOs for neurology companies 2006-2017
- U.S. venture investments in neurology companies from 2006 to 2017
- U.S. venture investments in psychiatry companies from 2006 to 2017
- U.S. psychiatry company IPO financing 2006-2017
- U.S. number of venture capital deals for psychiatry companies 2006-2017
- U.S. investment for emerging therapeutic companies 2015-2016
- U.S. investment for emerging therapeutic companies 2008-2017
- U.S. number of venture capital deals for cardiovascular companies 2006-2017
- R&D spending and CRO market size in the U.S. pharma industry 2012-2015
- Top pharmaceutical companies by SG&A to revenue rate 2017
- Increasing U.S. hospital costs of common conditions
- Pharmaceutical company value among Chinese top 500 firms 2017
- Pharmaceutical companies: marketing expenditure as share of sales 2013
Topics
Studies
- Pharmaceutical trends in Europe
- Indicatori Farmaceutici
- Vaccine industry in China
- The State of Innovation in Highly Prevalent Chronic Diseases 2019
- Pharmaceutical industry in India
- Pharmaceutical industry in Italy
- Pharmaceutical industry in Japan
- Pharmaceutical industry in China
- Pharmaceutical industry in the Netherlands
- Generic Pharmaceutical Industry Yearbook 2016
- LEO Pharma A/S Annual Report 2017
- Great Expectations: Why Pharma Companies Can’t Ignore Patient Services
- 2019 PhRMA Annual Membership Survey
- Medtronic - 2019 Form 10-K
- California Life Sciences Industry Report 2019
Statistics on "Pharmaceutical industry in Norway "
- Value of pharmaceutical sales in Norway from 2000 to 2017 (in milllion NOK)
- Leading pharmaceutical companies in Norway in 2017, by turnover (in million NOK)
- Leading pharmaceutical companies in Norway in 2017, by market share
- Producer price index (PPI) of chemical and pharmaceutical products in Norway from 2008 to 2018
- Public expenditure on blue prescriptions in Norway from 2013 to 2017 (in billion NOK)
- Number of pharmaceuticals available in Norway from 2013 to 2017
- Leading nonprescription pharmaceutical companies in Norway in 2017, by market share
- Turnover of pharmaceutical preparation manufacturers in Norway from 2007 to 2015 (in million NOK)
- Number of establishments in the manufacture of pharmaceutical preparations industry in Norway from 2007 to 2017
- Number of employees in the manufacture of pharmaceutical preparations industry in Norway from 2007 to 2017
- Import and export value of basic pharmaceutical products and pharmaceutical preparations in Norway in 2018 (in million NOK)
- Import value of basic pharmaceutical products and pharmaceutical preparations into Norway from 2008 to 2018 (in million NOK)
- Export value of basic pharmaceutical products and pharmaceutical preparations from Norway from 2008 to 2018 (in million NOK)
- Turnover share of prescription pharmaceuticals in Norway in 2017, by prescription type (in million NOK)
- Turnover of pharmaceuticals in Norway in 2017, by prescription type (in million NOK)
- Turnover share of generic pharmaceuticals in Norway from 2013 to 2017
- Turnover of pharmaceuticals in Norway in 2017, by type of drug (in million NOK)
- Turnover of pharmaceuticals in Norway in 2017, by ATC main groups (in million NOK)
- Turnover of nonprescription drugs in Norway from 2013 to 2017 (in million NOK)
- Number of patents in the biotechnology sector in Norway from 2011 to 2016
- Number of applications for clinical trials in Norway from 2013 to 2017
- Number of applications for clinical trials in Norway from 2013 to 2017, by type of actor
- Volume share of pharmaceutical sales Norway in 2016, by introduction date
- Number of new cancer pharmaceuticals approved by the European Medicines Agency (EMA) in Norway from 2014 to 2017
- Number of new and expired active substances in Norway from 2013 to 2017
- Share of total disease investment in the U.S. between 2008 and 2017, by disease
- Share of licensing and acquisition deals of therapeutic companies worldwide between 2008 and 2017, by disease
- Distribution of total disease investment in the U.S. between 2008 and 2017, by disease and investment type
- Number of venture capital deals for neurology companies in the U.S. from 2006 to 2017
- Venture investments in infectious disease companies in the U.S. from 2006 to 2017 (in million U.S. dollars)
- Number of venture capital deals for infectious disease companies in the U.S. from 2006 to 2017
- Number of venture capital deals for oncology companies in the U.S. from 2006 to 2017
- Number of initial public offerings (IPOs) for neurology companies in the U.S. from 2006 to 2017*
- Venture investments in neurology companies in the U.S. from 2006 to 2017 (in million U.S. dollars)
- Venture investments in psychiatry companies in the U.S. from 2006 to 2017 (in million U.S. dollars)
- Amount raised through initial public offerings (IPOs) from psychiatry companies in the U.S. from 2006 to 2017 (in million U.S. dollars)*
- Number of venture capital deals for psychiatry companies in the U.S. from 2006 to 2017
- Investment for emerging therapeutic companies in the U.S. 2015 vs. 2016 (in billion U.S. dollars)
- Investment for emerging therapeutic companies in the U.S. between 2008 and 2017 (in billion U.S. dollars)
- Number of venture capital deals for cardiovascular companies in the U.S. from 2006 to 2017
- R&D spending and CRO market size in the U.S. pharmaceutical industry from 2012 to 2015 (in billion U.S. dollars)*
- SG&A to revenue rate of top pharmaceutical companies in 2017*
- Common conditions with the most rapidly increasing hospital inpatient costs 2001–2007 in the U.S. (in percentage change)
- Market value of the leading Chinese pharmaceutical companies according to the ranking of East Money Information in 2017 (in billion U.S. dollars)
- Top pharmaceutical companies' expenditure on marketing as a percentage of sales in 2013
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.